Asset Acquisition, Consideration Transferred, Cancellation Of Liabilities

No definition available.

Name:	amag_AssetAcquisitionConsiderationTransferredCancellationOfLiabilities
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Asset Acquisition, Consideration Transferred, Gross

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionConsiderationTransferredGross
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Asset Acquisition, Consideration Transferred, Net

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionConsiderationTransferredNet
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Asset Acquisition, Contingent Consideration, Liability

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionContingentConsiderationLiability
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Asset Acquisition, Discount Rate

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionDiscountRate
Namespace Prefix:	amag_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Indefinite-Lived Intangibles

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibles
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Asset Acquisition, Recognized Identifiable Assets Acquired And Liabilities Assumed, Intangibles

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Asset Acquisitions, Liabilities, Other

+ References

No definition available.

+ Details

Name:	amag_AssetAcquisitionsLiabilitiesOther
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments For Asset Acquisitions

+ References

No definition available.

+ Details

Name:	amag_PaymentsForAssetAcquisitions
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments Related to Collaborative Arrangement

+ References

No definition available.

+ Details

Name:	amag_PaymentsRelatedToCollaborativeArrangement
Namespace Prefix:	amag_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349

+ Details

Name:	us-gaap_LossContingencyLossInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585

+ Details

Name:	us-gaap_PaymentsOfDebtExtinguishmentCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=amag_EndoceuticsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amag_PalatinTechnologiesInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=amag_IntrarosaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=amag_DeliveryOfIntrarosaLaunchQuantitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=amag_FirstAnniversaryOfClosingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=amag_VyleesiProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=amag_RegulatoryMilestoneAchievementAcceptanceByU.S.FoodAndDrugAdministrationOfNewDrugApplicationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=amag_RegulatoryMilestoneAchievementU.S.FoodAndDrugAdministrationApprovalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=amag_FailureToSupplyACertainPercentageOfProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=amag_PrascoLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	amag_AssetAcquisitionAxis=amag_PerospherePharmaceuticalsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=amag_PerosphereConvertibleNoteMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=amag_PerosphereTermLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Acquisitions, Collaboration, License and Other Strategic Agreements - Narrative (Details) - USD ($)			1 Months Ended			3 Months Ended		12 Months Ended
	Jan. 16, 2019	Apr. 03, 2017	Jul. 31, 2019	Jun. 30, 2018	Feb. 28, 2017	Jun. 30, 2019	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Jan. 31, 2017
Endoceutics, Inc.
Collaborative Agreements
Consideration recorded									$ 83,500,000
Payments related to collaborative arrangement		$ 50,000,000.0
Number of shares issued under arrangement (in shares)		600,000
Net shares issued in connection with license agreement, value		$ 13,500,000
IPR&D expense									5,800,000
Palatin Technologies, Inc.
Collaborative Agreements
Payments related to collaborative arrangement					$ 60,000,000.0
Out-of-pocket expenses (up to)					$ 25,000,000.0
Intrarosa \| Endoceutics, Inc.
Collaborative Agreements
Payments related to collaborative arrangement							$ 6,000,000.0
Out-of-pocket expenses (up to)							$ 20,000,000.0
Intrarosa \| Endoceutics, Inc. \| Developed Technology Rights
Collaborative Agreements
Finite-lived intangible assets									77,700,000
Intrarosa \| Endoceutics, Inc. \| Delivery Of Intrarosa Launch Quantities
Collaborative Agreements
Payments related to collaborative arrangement									$ 10,000,000.0
Intrarosa \| Endoceutics, Inc. \| First Anniversary Of Closing
Collaborative Agreements
Payments related to collaborative arrangement								$ 10,000,000.0
Vyleesi Products \| Palatin Technologies, Inc. \| Regulatory Milestone Achievement, Acceptance by U.S.Food and Drug Administration of New Drug Application
Collaborative Agreements
Payments related to collaborative arrangement				$ 20,000,000.0
Vyleesi Products \| Palatin Technologies, Inc. \| Regulatory Milestone Achievement, U.S.Food And Drug Administration Approval
Collaborative Agreements
Future contingent payments (up to)										$ 60,000,000.0
Failure To Supply A Certain Percentage Of Product \| Prasco, LLC
Collaborative Agreements
Failure to supply, penalties						$ 3,500,000
Perosphere Pharmaceuticals Inc.
Collaborative Agreements
Consideration recorded	$ 50,000,000.0
Payments of asset acquisitions	40,000,000.0
Cancellation of convertible note	10,000,000.0
Other liabilities	6,200,000
Cash consideration	$ 60,800,000
Discount rate	34.00%
Perosphere Pharmaceuticals Inc. \| Perosphere Convertible Note \| Convertible Debt
Collaborative Agreements
Aggregate principal amount of debt issued	$ 10,000,000.0
Perosphere Pharmaceuticals Inc. \| Perosphere Term Loan \| Line of Credit
Collaborative Agreements
Payment for debt extinguishment	$ 12,000,000.0
Subsequent Event \| Vyleesi Products \| Palatin Technologies, Inc. \| Regulatory Milestone Achievement, U.S.Food And Drug Administration Approval
Collaborative Agreements
Payments related to collaborative arrangement			$ 60,000,000.0